Multiple studies have found that SAA is upregulated in the serum of patients with various malignant tumors, such as gastric cancer, cervical cancer, and ovarian cancer, and its levels are closely associated with tumor occurrence, progression, and prognosis [21,22]. The gene discussed is SAA1; the disease is neoplasm.